Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural... see more

GREY:ISCNF - Post Discussion

Isracann Biosciences Inc > $IPOT- An cannabis company to add to portfolio
View:
Post by maysilverstone on Jun 15, 2021 5:37pm

$IPOT- An cannabis company to add to portfolio

With Israel just electing a new PM, cannabis going to be legalized very soon. To make bank on the new laws, a great Israel-associated cannabis company to add to your portfolio is $IPOT.
 
Up 4.3% today to $0.24, Isracann Biosciences is an Israeli-based cannabis company that is focused on offering low-cost production targeting undersupplied, major European marketplaces.
 
They have completed all requisite construction/infrastructural installations in preparation for the commencement of planting and production at its Hefer Valley-based Ein Hahoresh Farm, and they are just waiting for an inspection of the facility.
 
The European cannabis market is expected to see a 29.6% CAGR from 2020-2027, with the EU medical market estimated to be $64B USD by 2028. Israel itself is among the highest cannabis use per capita in the world at over 27%, representing a massive market.
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities